Histone Deacetylase Inhibitors Promote Breast Cancer Metastasis by Elevating NEDD9 Expression

Scientists demonstrated that FAK inhibitors could reverse breast cancer metastasis induced by upregulation of NEDD9 via pan-histone deacetylase inhibitors, which might offer a potential combination therapy for breast cancer.